Pacira Biosciences Inc at RBC Capital Markets Global Healthcare Conference Transcript

May 16, 2023 / 07:05PM GMT
Greg Renza - RBC Capital Markets - Analyst

Welcome back, everyone, to the 2023 RBC Global Healthcare Conference. My name is Greg Renza, one of the senior biotech equity research analysts here at RBC. And we're pleased to be joined by Pacira BioSciences.

Joining us from the company, of course, is the Chairman and CEO, Dave Stack, as well as the Chief Strategy Officer, Ron Ellis. Gentlemen, thanks for joining us.

Dave Stack - Pacira BioSciences, Inc. - CEO and Chairman

Thanks for the opportunity, Greg.

Questions and Answers:

Greg Renza - RBC Capital Markets - Analyst

Yeah. So why don't we dive right in? Certainly, a lot of interesting dynamics when it comes to the surgical environment with EXPAREL and the commercial drivers. But maybe, Dave, we can just have you take a step back and give us a brief overview of Pacira and just the current franchises in non-opioid pain relief.

Dave Stack - Pacira BioSciences, Inc. - CEO and Chairman

Yeah. Thank you, Greg. We
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot